NCT01444417 2017-02-09Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric PatientsAmgenPhase 3 Completed62 enrolled 16 charts 1 FDA
NCT00515203 2014-07-25Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric SubjectsAmgenPhase 1/2 Completed22 enrolled 13 charts 1 FDA